Is Evelo Biosciences, Inc. (EVLO) a Buy, Sell, or Hold?
OTC : EVLO
Evelo Biosciences, Inc. — Institutional Ownership
$0.0001 USD
$0 (0.0%)
- Volume
- 133
- Average Volume
- 577.82
- Market Capitalization
- $1.9K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.16
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-08-10 | Abigail P. Johnson | 2.45M | 14.75% |
| 2023-08-10 | FMR LLC | 2.45M | 14.75% |
| 2023-07-21 | HVST-TOPE LLC | 1.45M | 8.80% |
| 2023-07-21 | HarbourVest Partners L.P. | 1.45M | 8.80% |
| 2023-07-21 | SMRS-TOPE LLC | 1.45M | 8.80% |
| 2023-07-21 | Horizon Technology Finance Corporation | 2.16M | 11.50% |
| 2023-07-21 | HarbourVest Partners, LLC | 1.45M | 8.80% |
| 2022-08-23 | DNCA FINANCE S.C.S | 920.0 | 3.63% |
| 2021-12-28 | DNCA FINANCE S.C.S | 688.0 | 5.03% |
| 2021-02-16 | 10 | 3.06M | 6.60% |
| 2021-02-16 | 10 | 3.06M | 6.60% |
| 2021-02-16 | 10 | 3.06M | 6.60% |
| 2021-02-16 | 10 | 3.06M | 6.60% |
| 2021-02-12 | CREDIT SUISSE AG/000000000 | 2.71M | 5.00% |
| 2018-07-10 | FMR LLC | 3.31M | 10.44% |
| 2018-05-21 | 1,763,505 | 1.76M | 5.50% |
| 2018-05-21 | 1,763,505 | 1.76M | 5.50% |
| 2018-05-21 | 1,763,505 | 1.76M | 5.50% |
| 2018-05-21 | 1,763,505 | 1.76M | 5.50% |
| 2018-05-18 | LLP | 379.5K | 8.30% |
| 2018-05-18 | General Partner LLP | 379.5K | 8.30% |
| 2018-05-18 | LP | 379.5K | 8.30% |
| 2018-05-18 | GP LP | 379.5K | 8.30% |
EVLO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $32.20 | 4.36M | $140.34M | $47.94M | $51.14M | $143.54M |
| 2021-12-31 | $121.40 | 2.65M | $321.17M | $68.44M | $56.29M | $309.02M |
| 2020-12-31 | $241.80 | 1.97M | $477.3M | $68.86M | $40.04M | $448.48M |
| 2019-12-31 | $81.20 | 1.6M | $130.05M | $77.83M | $19.63M | $71.85M |
| 2018-12-31 | $260.20 | 1.09M | $284.54M | $147.92M | $12.3M | $148.93M |
| 2017-12-31 | $320.00 | 187K | $59.84M | $38.25M | $9.97M | $31.56M |
| 2016-12-31 | $320.00 | 141K | $45.12M | $15.54M | $9.93M | $39.52M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-09-30 | $3.92 | 173.84K | $681.46K | $17.26M | $33.95M | $17.37M |
| 2023-06-30 | $3.25 | 5.58M | $18.13M | $7.62M | $50.48M | $60.99M |
| 2023-03-31 | $3.62 | 5.54M | $20.07M | $27.47M | $50.7M | $43.3M |
| 2022-12-31 | $32.20 | 5.49M | $176.84M | $47.94M | $51.14M | $180.04M |
| 2022-09-30 | $41.80 | 5.4M | $225.83M | $69.05M | $54.86M | $211.63M |
| 2022-06-30 | $42.20 | 3.79M | $159.77M | $92.01M | $55.34M | $123.11M |
| 2022-03-31 | $67.80 | 2.68M | $181.77M | $39.63M | $55.83M | $197.97M |
| 2021-12-31 | $121.40 | 2.68M | $324.74M | $68.44M | $56.29M | $312.6M |
| 2021-09-30 | $140.80 | 2.67M | $376.08M | $95.94M | $56.77M | $336.91M |
| 2021-06-30 | $274.80 | 2.67M | $733.17M | $123.33M | $57.22M | $667.05M |
| 2021-03-31 | $214.00 | 2.57M | $549.34M | $124.59M | $41.38M | $466.12M |
| 2020-12-31 | $241.80 | 2.34M | $564.6M | $68.86M | $40.04M | $535.78M |